<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="bjh15394-tbl-0005" xml:lang="en" orientation="portrait" position="float">
 <label>Table 5</label>
 <caption>
  <p>Confirmed best response to treatment among response‐evaluable patients, by study phase and overall</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Response rate, 
     <italic>n</italic> (%) [95% CI]
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">Phase 1 
     <italic>n </italic>=
     <italic> </italic>13
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">Phase 2 
     <italic>n </italic>=
     <italic> </italic>49
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">mITT 
     <italic>n </italic>=
     <italic> </italic>56
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">Patients who entered the maintenance period 
     <italic>n </italic>=
     <italic> </italic>18
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">Total 
     <italic>N </italic>=
     <italic> </italic>62
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">ORR (≥PR)</td>
    <td align="left" rowspan="1" colspan="1"> 12 (92)
     <break/> [64, 100] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 46 (94)
     <break/> [83, 99] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 53 (95)
     <break/> [85, 99] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 17 (94)
     <break/> [73, 100] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 58 (94)
     <break/> [84, 98] 
    </td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">CR + VGPR</td>
    <td align="left" rowspan="1" colspan="1"> 10 (77)
     <break/> [46, 95] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 32 (65)
     <break/> [50, 78] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 38 (68)
     <break/> [54, 80] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 16 (89)
     <break/> [65, 99] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 42 (68)
     <break/> [55, 79] 
    </td>
   </tr>
   <tr>
    <td align="left" style="padding-left:15%" rowspan="1" colspan="1">CR</td>
    <td align="left" rowspan="1" colspan="1"> 1 (8)
     <break/> [0, 36] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 14 (29)
     <break/> [17, 43] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 15 (27)
     <break/> [16, 40] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 8 (44)
     <break/> [22, 69] 
    </td>
    <td align="left" rowspan="1" colspan="1"> 15 (24)
     <break/> [14, 37] 
    </td>
   </tr>
   <tr>
    <td align="left" style="padding-left:15%" rowspan="1" colspan="1">sCR</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">11 (22)</td>
    <td align="left" rowspan="1" colspan="1">11 (20)</td>
    <td align="left" rowspan="1" colspan="1">5 (28)</td>
    <td align="left" rowspan="1" colspan="1">11 (18)</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:15%" rowspan="1" colspan="1">VGPR</td>
    <td align="left" rowspan="1" colspan="1">9 (69)</td>
    <td align="left" rowspan="1" colspan="1">18 (37)</td>
    <td align="left" rowspan="1" colspan="1">23 (41)</td>
    <td align="left" rowspan="1" colspan="1">8 (44)</td>
    <td align="left" rowspan="1" colspan="1">27 (44)</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:15%" rowspan="1" colspan="1">nCR</td>
    <td align="left" rowspan="1" colspan="1">2 (15)</td>
    <td align="left" rowspan="1" colspan="1">5 (10)</td>
    <td align="left" rowspan="1" colspan="1">6 (11)</td>
    <td align="left" rowspan="1" colspan="1">4 (22)</td>
    <td align="left" rowspan="1" colspan="1">7 (11)</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PR</td>
    <td align="left" rowspan="1" colspan="1">2 (15)</td>
    <td align="left" rowspan="1" colspan="1">14 (29)</td>
    <td align="left" rowspan="1" colspan="1">15 (27)</td>
    <td align="left" rowspan="1" colspan="1">1 (6)</td>
    <td align="left" rowspan="1" colspan="1">16 (26)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">MR</td>
    <td align="left" rowspan="1" colspan="1">1 (8)</td>
    <td align="left" rowspan="1" colspan="1">3 (6)</td>
    <td align="left" rowspan="1" colspan="1">3 (5)</td>
    <td align="left" rowspan="1" colspan="1">1 (6)</td>
    <td align="left" rowspan="1" colspan="1">4 (6)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Stable disease</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Progressive disease</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
    <td align="left" rowspan="1" colspan="1">0</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="bjh15394-note-0013">
   <p>CI, confidence interval; CR, complete response; mITT, modified intent to treat; MR, minimal response; nCR, near complete response; ORR, overall response rate; PR, partial response; sCR, stringent complete response; VGPR, very good partial response.</p>
  </fn>
  <fn id="bjh15394-note-0014">
   <p>62 of 64 patients were evaluable for response (2 patients did not have post‐baseline response assessments; thus were not evaluable). Data are 
    <italic>n</italic> (%) or 
    <italic>n</italic> (%) [95% CI].
   </p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
